|
|
||||||||
Allergy, Schering-Plough Research Institute, Kenilworth, New Jersey 07033
Anesthetized
Sprague-Dawley weanling rats were scanned for bone mineral density
(BMD) values after 7 days of treatment to determine whether
resorption/growth at the proximal tibia can be quantified by peripheral
quantitative computed tomography scanning techniques. Because the
weanling rat is in a rapid growth stage, all groups showed significant
increases in change from baseline values of BMD. Bisphosphonate
treatment produced significant dose-related changes in BMD with average
increases of 195 and 241% (10 and 20 µg/kg) vs. 86% in control
rats. We further characterized this model to determine effects of
steroids on growing bone. Graded doses of glucocorticoid (3.5, 7.0, 10.5, 14.0, 28.0, and 42.0 mg · kg
1 · wk
1)
caused no significant differences in trabecular BMD in 7 days between
control and treated rats. Significant decreases in growth (weights) and
increases in cortical bone area were observed, indicating that this
model may be useful in comparing effects of nonsteroid, anti-inflammatory alternatives on juvenile bone. Although the relevance
of this model to adult disease remains to be elucidated, it also
provides a tool for mechanistic evaluation of therapeutic modalities or efficacy assessment for dose selection for
longerterm models.
osteoporosis; bone mineral density; glucocorticoid; computed tomography; animal model
This article has been cited by other articles:
![]() |
N. A. McHugh, H. M. Vercesi, R. W. Egan, and J. A. Hey Receptor activator of NF-{kappa}B ligand arrests bone growth and promotes cortical bone resorption in growing rats J Appl Physiol, August 1, 2003; 95(2): 672 - 676. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |